Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

NCT04547855 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: anlotinib combined with dose-dense temozolomide

Sponsor

Yonggao Mou

Collaborators

[object Object]